from syringes to insulin pens, to an insulin pump, or even with an inhaler. Maintaining blood glucose levels helps reduce the risk of diabetes complications, such as blindness and the loss of limbs.

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The US diabetes market generated US$11.2 billion sales in 2006 as compared to $9.6 billion in 2005. Metformin, the sulphonylureas and the TZDs were the most prescribed classes of non-insulin ...

Hyperglycemia is a marker for poor clinical outcome and mortality in hospitalized patients. In the critical care setting, insulin administered intravenously or subcutaneously is effective.

More information: Roy W. Beck et al, A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes, Diabetes Technology & Therapeutics (2025 ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. The Danish drugmaker ...

and store the insulin pens. Patient selection. Patients were eligible for study inclusion if they had documentation of type 1 or 2 diabetes mellitus in their medical record, required subcutaneous ...

and cost savings with insulin pens versus conventional insulin delivery via vials and syringes in hospitalized patients with diabetes were compared. Methods: Patients were recruited from two ...